Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Remdesivir

Tag: Remdesivir

  • BiotechToday
  • World

VV116 vs. Nirmatrelvir-Ritonavir Against COVID-19

DNA tales April 23, 2023April 23, 2023

Tholkappian R, NIT Durgapur Nirmatrelvir is an oral inhibitor of the SARS-CoV-2’s, 3-chymotrypsin–like cysteine protease, while VV116 is a deuterated remdesivir hydro-bromide with potent activity against SARS-CoV-2. Nirmatrelvir-ritonavir was used to treat COVID-19 of low to moderate severity. However, its production could not meet the global supply demands. VV116 is one such oral analog of […]

Read More
  • Biotechnopedia
  • DNA-Tales

Neurological Effects in COVID-19 Patients

DNA tales August 9, 2021August 9, 2021

Aayushi Gaur, U. I. E. T., Kurukshetra University Doctors battled to keep patients breathing in the early months of the COVID-19 pandemic, focusing mostly on treating lung and circulatory system damage. However, evidence of neurological consequences was already collecting at the time. Some COVID-19 patients were suffering from delirium, which manifested as confusion, disorientation, and […]

Read More
  • BiotechToday
  • World

Shionogi is in a race against Pfizer and Merck

BioTech Today August 4, 2021August 4, 2021 2

Sneha Singhal, Jaypee Institute of information technology, Noida Pfizer Inc. and Merck & Co. in the race to find treatments for Covid-19 have joined a Japanese company in starting human trials for the first once-daily pill. Shionogi and Co., of Osaka, claimed that its pill would neutralize the Coronavirus in five days or less. The […]

Read More
  • BiotechToday
  • India

Drugs like ivermectin, doxycycline, Hydroxychloroquine removed in revised Covid-19 guidelines

BioTech Today June 14, 2021June 14, 2021 1

Saptaparna Pal, Amity University Kolkata The Union Health Ministry’s Directorate General of Health Sciences (DGHS) has proposed revised Covid-19 guidelines and removed all medicines except antipyretic (fever) and antitussive (cold) for mild and asymptomatic cases. The revised Covid-19 guidelines issued on 27 May 2021 dropped all medicines that the doctors have been prescribing even to […]

Read More
  • BiotechToday
  • World

Remdesivir resistant SARS-CoV-2!

bioxone January 6, 2021January 5, 2021 1

Parnad Basu, Amity University Kolkata Remdesivir (C27H35N6O8P), is a broad-spectrum antiviral medication. It is administered via injection into a vein. Before the completion of clinical trials of the COVID-19 vaccines, remdesivir will be used to fight COVID-19. Now, COVID-19 is always mutating. And it is important to study those mutations to make remdesivir more effective […]

Read More
  • BiotechToday
  • World

Neutrophil-derived Nanovesicles: A Novel Drug Delivery System

bioxone December 13, 2020December 12, 2020 3

Sayak Banerjee. Amity University Kolkata Scientists at Washington State University (WSU) discovered that other than immune cells, neutrophils also might play a major role in defense against infection, through a new drug delivery technology. Neutrophils are the most common type of white blood cells (WBCs) that lead the body’s immune system response. They established a […]

Read More
  • BiotechToday
  • World

Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

bioxone December 1, 2020December 1, 2020 1

Souradip Mallick, National Institute of Technology, Rourkela The emergence of SARS-CoV-2 virus has resulted in a worldwide pandemic killed over 1,368,000 people globally (WHO). Currently, effective treatments to inhibit SARS-CoV-2 morbidity and mortality are not available. The pharmacological screen identified several compounds capable of blocking the in vitro replication of two beta-coronaviruses. Among many ones […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy